Literature DB >> 20809127

Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.

M Voth1, Henrik J Michaely, C Schwenke, B Vos, H Pietsch.   

Abstract

OBJECTIVE: To compare the image quality of contrast-enhanced magnetic resonance angiography (CE-MRA) of the supra-aortic vessels at 0.05 mmol/kg bw and 0.1 mmol/kg bw, between gadobutrol, Gd-DTPA and Gd-BOPTA quantitatively and qualitatively a total of eight pigs were evaluated intraindividually at 1.5 T.
METHODS: Each pig was examined using 0.1 mmol/kg gadobutrol, Gd-DTPA and Gd-BOPTA on day one and 0.05 mmol/kg on day two. MRA datasets for the carotid artery and the infraorbital artery were qualitatively assessed regarding overall image quality on an ordinal four-point scale (4-excellent, 1-non-diagnostic). The signal-to noise-ratio (SNR) was measured.
RESULTS: The qualitative assessment of the carotid artery showed a higher median image quality for the 0.1 mmol dose than for the 0.05 mmol dose for all three compounds. No difference was found for the infraorbital artery. Mean SNR of Gd-BOPTA, Gd-DTPA, gadobutrol at 0.05 mmol/kg were 36.0 ± 13.4/37.9 ± 16.3/43.7 ± 0.4 and at 0.1 mmol/kg they were 50.1 ± 12.4/46.6 ± 6.5 / 54.6 ± 10.2. Gd-BOPTA 0.05 revealed a significantly lower SNR than all other agents at normal dose.
CONCLUSIONS: Full-dose gadolinium MRA results in higher image quality and significantly higher SNR compared with the half dose. Gadobutrol and Gd-BOPTA have similar enhancement properties at full dose but at half dose, gadobutrol appears superior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809127     DOI: 10.1007/s00330-010-1940-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol.

Authors:  Bernd Tombach; Thomas Benner; Peter Reimer; Gerhard Schuierer; Eva-Maria Fallenberg; Viviane Geens; Thomas Wels; A Gregory Sorensen
Journal:  Radiology       Date:  2003-01-31       Impact factor: 11.105

Review 2.  Magnetic resonance angiography of abdominal and lower extremity vasculature.

Authors:  Tim Leiner
Journal:  Top Magn Reson Imaging       Date:  2005-02

3.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

4.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

5.  Does a higher concentration of gadolinium chelates improve first-pass cardiac signal changes?

Authors:  B Tombach; P Reimer; B Prümer; T Allkemper; C Bremer; A Mühler; W Heindel
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

6.  Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience.

Authors:  Mathias Goyen; Christoph U Herborn; Florian M Vogt; Knut Kröger; Rüdiger Verhagen; Fan Yang; Silke Bosk; Jörg F Debatin; Stefan G Ruehm
Journal:  J Magn Reson Imaging       Date:  2003-05       Impact factor: 4.813

7.  Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography.

Authors:  Christoph U Herborn; Thomas C Lauenstein; Stefan G Ruehm; Silke Bosk; Jörg F Debatin; Mathias Goyen
Journal:  Invest Radiol       Date:  2003-01       Impact factor: 6.016

8.  Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.

Authors:  Matthias Voth; Stefan Haneder; Kurt Huck; Alexandra Gutfleisch; Stefan O Schönberg; Henrik J Michaely
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

9.  Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.

Authors:  Christian Fink; Michael Bock; Fabian Kiessling; Matthias Philipp Lichy; Radko Krissak; Ivan Zuna; Astrid Schmähl; Stefan Delorme; Hans-Ulrich Kauczor
Journal:  J Magn Reson Imaging       Date:  2004-02       Impact factor: 4.813

10.  Incidence of nephrogenic systemic fibrosis at two large medical centers.

Authors:  Martin R Prince; Honglei Zhang; Michael Morris; Jennifer L MacGregor; Marc E Grossman; Jeffrey Silberzweig; Robert L DeLapaz; Henry J Lee; Cynthia M Magro; Anthony M Valeri
Journal:  Radiology       Date:  2008-09       Impact factor: 11.105

View more
  2 in total

1.  Magnetic resonance angiography (MRA) of the calf station at 3.0 T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA.

Authors:  Stefan Haneder; Ulrike I Attenberger; Philipp Riffel; Thomas Henzler; Stefan O Schoenberg; Henrik J Michaely
Journal:  Eur Radiol       Date:  2011-01-28       Impact factor: 5.315

2.  Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion.

Authors:  Ulrike I Attenberger; John N Morelli; Stefan O Schoenberg; Henrik J Michaely
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-15       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.